Purification of modified vaccinia virus Ankara from suspension cell culture

被引：0
|
作者：
Ingo Jordan
Diana Weimer
Stefan Iarusso
Holger Bernhardt
Verena Lohr
Volker Sandig
机构：
[1] ProBioGen AG,Now at Sanofi
[2] Industriepark Höchst,Aventis Deutschland GmbH
来源：
BMC Proceedings | / 9卷 / Suppl 9期
关键词：
Monolithic Chromatography Column; Vaccine Dose; Infected Culture; Product Fraction; Modify Vaccinia Virus Ankara;
D O I：
10.1186/1753-6561-9-S9-O13
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Modified Vaccinia Virus Ankara (MVA) based Vaccines - Immunostimulatory and Protective Capacity
    Lehmann, Michael H.
    Kremer, Melanie
    Suezer, Yasemin
    Sutter, Gerd
    CHALLENGE OF HIGHLY PATHOGENIC MICROORGANISMS: MECHANISMS OF VIRULENCE AND NOVEL MEDICAL COUNTERMEASURES, 2010, : 245 - +
  • [32] Opposite effects of Vaccinia and modified Vaccinia Ankara on trained immunity
    Bastiaan A. Blok
    Kristoffer J. Jensen
    Peter Aaby
    Anders Fomsgaard
    Reinout van Crevel
    Christine S. Benn
    Mihai G. Netea
    European Journal of Clinical Microbiology & Infectious Diseases, 2019, 38 : 449 - 456
  • [33] Marker rescue of the host range restriction defects of modified vaccinia virus Ankara
    Wyatt, LS
    Carroll, MW
    Czerny, CP
    Merchlinsky, M
    Sisler, JR
    Moss, B
    VIROLOGY, 1998, 251 (02) : 334 - 342
  • [34] Human Mpox Virus Infection After Receipt of Modified Vaccinia Ankara Vaccine
    Zhou, Ya Bin
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 329 (12):
  • [35] Modified Vaccinia virus Ankara: Innate immune activation and induction of cellular signalling
    Price, Philip J. R.
    Torres-Dominguez, Lino E.
    Brandmueller, Christine
    Sutter, Gerd
    Lehmann, Michael H.
    VACCINE, 2013, 31 (39) : 4231 - 4234
  • [36] Transient host range selection for genetic engineering of modified vaccinia virus Ankara
    Staib, C
    Drexler, I
    Ohlmann, M
    Wintersperger, S
    Erfle, V
    Sutter, G
    BIOTECHNIQUES, 2000, 28 (06) : 1137 - +
  • [37] Development of Modified Vaccinia Virus Ankara-Based Vaccines: Advantages and Applications
    Orlova, Olga Vladimirovna
    Glazkova, Dina Viktorovna
    Bogoslovskaya, Elena Vladimirovna
    Shipulin, German Alexandrovich
    Yudin, Sergey Mikhailovich
    VACCINES, 2022, 10 (09)
  • [38] Hazard Characterization of Modified Vaccinia Virus Ankara Vector: What Are the Knowledge Gaps?
    Okeke, Malachy I.
    Okoli, Arinze S.
    Diaz, Diana
    Offor, Collins
    Oludotun, Taiwo G.
    Tryland, Morten
    Bohn, Thomas
    Moens, Ugo
    VIRUSES-BASEL, 2017, 9 (11):
  • [39] Modified vaccinia virus Ankara induces moderate activation of human dendritic cells
    Drillien, R
    Spehner, D
    Hanau, D
    JOURNAL OF GENERAL VIROLOGY, 2004, 85 : 2167 - 2175
  • [40] Evaluation of modified vaccinia virus Ankara based recombinant SARS vaccine in ferrets
    Czub, M
    Weingartl, H
    Czub, S
    He, RT
    Cao, JX
    VACCINE, 2005, 23 (17-18) : 2273 - 2279
12345